fda safety communication semaglutide naion 2025 Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning FDA-Approved Obesity Medications Timeline: Evolution

But if the stool is truly black, sticky, tar-like, and foul-smelling, it may still indicate digested blood

Proper assessment, monitoring, and follow-up care are essential to ensure a successful outcome

Nature Metabolism DOI:10.1038/s42255-026-01534-8 Abstract Semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-1 expressing hindbrain neurons Glucagon-like peptide 1 receptor (GLP1R) agonists, such as semaglutide, drive weight loss by binding to GLP1Rsclassically described as G s -coupled G-protein-coupled receptorsin the brain

Hot climate, dehydration risk, prolonged fasting patterns, and irregular meal timing may worsen gastrointestinal side effects in Indian settings